Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Mylan Pharmaceuticals has received final approval from the FDA for its abbreviated new drug application for verapamil hydrochloride extended-release capsules in 100mg, 200mg and 300mg doses.
Subscribe to our email newsletter
The verapamil capsules are the generic version of Elan Drug Delivery’s Verelan tablets for the treatment of high blood pressure.
Verapamil capsules had US sales of approximately $58 million for the 12 months ending June 30, 2007, for the same strengths.
Mylan’s product will be shipped immediately, the company said.